Skip to main content

Table 2 Perfusion parameters gained by VPCT and C-arm CT before and after TACE in HCC lesions and non-affected liver parenchyma

From: C-arm computed tomography and volume perfusion computed tomography (VPCT)-based assessment of blood volume changes in hepatocellular carcinoma in prediction of midterm tumor response to transarterial chemoembolization: a single center retrospective trial

Parameter

Number

Pre TACE

Post TACE

p-value

HCC lesions

PBV (ml/100 ml)

59

17.16 (±5.9)

2.7 (±4.2)

<0.0001

BF (ml/100 ml/min)

58

57.8 (±19.22)

26.58 (±19.87)

<0.0001

BV (ml/100 ml)

58

13.75 (±3.89)

7.06 (±5.07)

<0.0001

ALP (ml/100 ml/min)

58

47.40 (±15.02)

12.02 (±17.85)

<0.0001

HPI (%)

58

87.64 (±23.3)

24.72 (±32.35)

<0.0001

Non affected liver parenchyma

PBV (ml/100 ml)

25

3.16 (±1.67)

2.48 (±1.71)

0.0059

BF (ml/100 ml/min)

25

24.76 (±15.59)

34.13 (±16.66)

0.0005

BV (ml/100 ml)

25

7.23 (±3.67)

8.92 (±3.75)

0.0015

ALP (ml/100 ml/min)

25

10.23 (±7.08)

12.72 (±10.59)

0.1108

PVP (ml/100 ml/min)

25

62.68 (±19.31)

60.14 (±21.12)

0.6099

HPI (%)

25

16.22 (±10.03)

19.2 (±15.61)

0.4078

  1. The p-value indicates the level of significance. Arithmetic mean and standard deviation are given
  2. Abbreviations: PBV parenchymal blood volume, BF blood flow, BV blood volume, ALP arterial liver perfusion, PVP portal venous perfusion, HPI hepatic perfusion index, n number of cases